Literature DB >> 18362948

NLRs at the intersection of cell death and immunity.

Jenny P-Y Ting1, Stephen B Willingham, Daniel T Bergstralh.   

Abstract

Inflammation is a crucial element of the host response to cellular insult. Pathogen-induced inflammation includes a molecular pathway which proceeds through activation of the protease caspase-1 to the release of the inflammatory cytokines interleukin-1 (IL-1) and IL-18. Importantly, pathogens may also induce forms of cell death that have inherently pro-inflammatory features. Here, we review recent evidence demonstrating that NLR (nucleotide-binding domain, leucine-rich repeat containing) family proteins serve as a common component of both caspase-1-activated apoptotic pathways and caspase-independent necrotic pathways. Parallels are drawn between NLR protein function and the activity of structurally similar proteins involved in cell death: the apoptotic mediator APAF1 (apoptotic-protease-activating factor 1) and the plant disease resistance NBS-LRR (nucleotide-binding site leucine-rich repeats) proteins.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18362948     DOI: 10.1038/nri2296

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


  171 in total

1.  The MADS29 transcription factor regulates the degradation of the nucellus and the nucellar projection during rice seed development.

Authors:  Lin-Lin Yin; Hong-Wei Xue
Journal:  Plant Cell       Date:  2012-03-09       Impact factor: 11.277

Review 2.  How do plants achieve immunity? Defence without specialized immune cells.

Authors:  Steven H Spoel; Xinnian Dong
Journal:  Nat Rev Immunol       Date:  2012-01-25       Impact factor: 53.106

3.  Polypeptide modulators of caspase recruitment domain (CARD)-CARD-mediated protein-protein interactions.

Authors:  Yadira Palacios-Rodríguez; Guillermo García-Laínez; Mónica Sancho; Anna Gortat; Mar Orzáez; Enrique Pérez-Payá
Journal:  J Biol Chem       Date:  2011-11-07       Impact factor: 5.157

4.  A novel pathway for inducible nitric-oxide synthase activation through inflammasomes.

Authors:  Carina L Buzzo; Julia C Campopiano; Liliana M Massis; Silvia L Lage; Alexandra A Cassado; Rafael Leme-Souza; Larissa D Cunha; Momtchilo Russo; Dario S Zamboni; Gustavo P Amarante-Mendes; Karina R Bortoluci
Journal:  J Biol Chem       Date:  2010-08-11       Impact factor: 5.157

5.  Three-dimensional structure of the NLRP7 pyrin domain: insight into pyrin-pyrin-mediated effector domain signaling in innate immunity.

Authors:  Anderson S Pinheiro; Martina Proell; Clarissa Eibl; Rebecca Page; Robert Schwarzenbacher; Wolfgang Peti
Journal:  J Biol Chem       Date:  2010-06-11       Impact factor: 5.157

6.  A novel aminosaccharide compound blocks immune responses by Toll-like receptors and nucleotide-binding domain, leucine-rich repeat proteins.

Authors:  Kyoung-Hee Lee; Yuen-Joyce Liu; Amlan Biswas; Chikako Ogawa; Koichi S Kobayashi
Journal:  J Biol Chem       Date:  2010-12-07       Impact factor: 5.157

7.  Cutting edge: NLRC5-dependent activation of the inflammasome.

Authors:  Beckley K Davis; Reid A Roberts; Max T Huang; Stephen B Willingham; Brian J Conti; W June Brickey; Brianne R Barker; Mildred Kwan; Debra J Taxman; Mary-Ann Accavitti-Loper; Joseph A Duncan; Jenny P-Y Ting
Journal:  J Immunol       Date:  2010-12-29       Impact factor: 5.422

Review 8.  Innate immunity to adenovirus: lessons from mice.

Authors:  Svetlana Atasheva; Jia Yao; Dmitry M Shayakhmetov
Journal:  FEBS Lett       Date:  2019-12-08       Impact factor: 4.124

Review 9.  Type-I-interferons in infection and cancer: Unanticipated dynamics with therapeutic implications.

Authors:  Martina Musella; Gwenola Manic; Ruggero De Maria; Ilio Vitale; Antonella Sistigu
Journal:  Oncoimmunology       Date:  2017-04-05       Impact factor: 8.110

Review 10.  Tumor-host interactions: the role of inflammation.

Authors:  Marie-Aude Le Bitoux; Ivan Stamenkovic
Journal:  Histochem Cell Biol       Date:  2008-10-25       Impact factor: 4.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.